19 May 2013
Keywords: astrazeneca, reports, strong, results, symbicort, pediatric, trial
Article | 26 May 2008
Anglo-Swedish drug major AstraZeneca reported positive data for a study evaluating the safety and efficacy of its asthma treatment Symbicort
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 May 2008
17 May 2013
© 2013 thepharmaletter.com